Target Price | $33.50 |
Price | $9.47 |
Potential |
253.75%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Assembly Biosciences, Inc. 2026 .
The average Assembly Biosciences, Inc. target price is $33.50.
This is
253.75%
register free of charge
$36.00
280.15%
register free of charge
$31.00
227.35%
register free of charge
|
|
A rating was issued by 3 analysts: 2 Analysts recommend Assembly Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Assembly Biosciences, Inc. stock has an average upside potential 2026 of
253.75%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 28.52 | 31.66 |
298.32% | 11.00% |
3 Analysts have issued a sales forecast Assembly Biosciences, Inc. 2025 . The average Assembly Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
Dec '24 |
2025 Estimates |
|
---|---|---|
EV/Sales | negative |
Analyst | Rating | Action | Date |
---|---|---|---|
Guggenheim |
Locked
➜
Locked
|
Locked | Mar 25 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 27 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 24 2024 |
Jefferies |
Locked
➜
Locked
|
Locked | Sep 20 2024 |
Analyst Rating | Date |
---|---|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 25 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 27 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 24 2024 |
Locked
Jefferies:
Locked
➜
Locked
|
Sep 20 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.